Subscribe To
TFFP / TFF Pharmaceuticals, Inc. (TFFP) Reports Q4 Loss, Lags Revenue Estimates
TFFP News
By GlobeNewsWire
September 28, 2023
TFF Pharmaceuticals to Participate in Upcoming Investor Conferences
FORT WORTH, Texas, Sept. 28, 2023 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on more_horizontal
By InvestorPlace
February 23, 2023
3 Bargain Stocks Worth Buying at These 52-Week Lows
Who doesn't love a bargain? We look for deals in many places. more_horizontal
By Seeking Alpha
November 22, 2022
TFF Pharmaceuticals: From Undefeatable To Speculative
Almost everything has gone wrong since my first bullish article with TFF Pharmaceuticals. The stock is now severely depressed and, despite significant more_horizontal
By Seeking Alpha
November 14, 2022
TFF Pharmaceuticals, Inc. (TFFP) Q3 2022 Earnings Call Transcript
TFF Pharmaceuticals, Inc. (NASDAQ:TFFP ) Q3 2022 Earnings Conference Call November 14, 2022 5:00 PM ET Company Participants Corey Davis - LifeSci Advi more_horizontal
By Seeking Alpha
August 29, 2022
TFF Pharma: The Potential Is Still Very Much Present
While the company added three more big pharma partners, this is not what shareholders prefer to hear as the company already has more than two dozen of more_horizontal
By Seeking Alpha
August 9, 2022
TFF Pharmaceuticals: Q3 Data Is Pivotal In So Many Ways
Once promising, TFF Pharma is now cash-strapped and stagnant. TFFP badly needs some good news. more_horizontal
By Seeking Alpha
May 23, 2022
TFF Pharmaceuticals: A Highly Attractive Basket Of Options
TFFP is a platform company with leading technology. Clinical/FDA risk is extremely low. more_horizontal
By Seeking Alpha
May 11, 2022
TFF Pharmaceuticals, Inc. (TFFP) CEO Glenn Mattes on Q1 2022 Results - Earnings Call Transcript
TFF Pharmaceuticals, Inc. (NASDAQ:TFFP ) Q1 2022 Earnings Conference Call May 11, 2022 4:30 PM ET Company Participants Corey Davis - LifeSci Advisors more_horizontal